C Mitroi1, A Martín-García2, P Mazón Ramos3, J A Virizuela Echaburu4, M Arenas-Prat5, R García-Sanz6, V Arrarte Esteban7, J M García-Pinilla8, J Cosín-Sales9, T López-Fernández10. 1. Cardiology Department, University Hospital Puerta de Hierro, Majadahonda, Manuel de Falla 1, 28222, Madrid, Spain. cristina_mitroi@hotmail.com. 2. Cardiology Department, Institute for Biomedical Research of Salamanca (IBSAL), CIBER-CV, University Hospital of Salamanca (CAUSA), Salamanca, Spain. 3. Cardiology Department, University Clinical Hospital Santiago de Compostela, Santiago de Compostela, A Coruña, Spain. 4. Medical Oncology Department, Hospital Virgen Macarena, Seville, Spain. 5. Radiation Oncology Department, University Hospital Sant Joan de Reus, Rovira i Virgili University, Reus, Tarragona, Spain. 6. Hematology Department, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca (CAUSA), Salamanca, Spain. 7. Cardiology Department, University General Hospital Alicante, Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. 8. Cardiology Department, IBIMA, CIBER-CV, University Hospital Virgen de la Victoria, Málaga, Spain. 9. Cardiology Department, Arnau de Vilanova Hospital, Valencia, Spain. 10. Cardiology Department, Institute for Health Research La Paz, CIBER-CV, University Hospital La Paz, Madrid, Spain.
Abstract
PURPOSE: The aim of the current survey was to describe the functioning of cardio-oncology (C-O) units in Spain. METHODS: All members of the Spanish Society of Cardiology pertaining to scientific communities related to C-O received questionnaires on the existence of specific programs at their institutions. A second, more extensive questionnaire was sent to the centers which reported C-O organization. RESULTS: We identified 56 centers with C-O programs of which 32 (62.5%) replied to the extended questionnaire. 28% of all centers reported having a multidisciplinary unit involving specialists in several areas. More than 80% of the centers developed surveillance protocols locally adapted which included advanced echocardiographic techniques (68%) or troponin (82%). CONCLUSIONS: The number of institutions with C-O programs is still limited but higher than reported in a survey in 2017. Development of multidisciplinary units of C-O should be promoted to improve the cardiovascular health of cancer patients.
PURPOSE: The aim of the current survey was to describe the functioning of cardio-oncology (C-O) units in Spain. METHODS: All members of the Spanish Society of Cardiology pertaining to scientific communities related to C-O received questionnaires on the existence of specific programs at their institutions. A second, more extensive questionnaire was sent to the centers which reported C-O organization. RESULTS: We identified 56 centers with C-O programs of which 32 (62.5%) replied to the extended questionnaire. 28% of all centers reported having a multidisciplinary unit involving specialists in several areas. More than 80% of the centers developed surveillance protocols locally adapted which included advanced echocardiographic techniques (68%) or troponin (82%). CONCLUSIONS: The number of institutions with C-O programs is still limited but higher than reported in a survey in 2017. Development of multidisciplinary units of C-O should be promoted to improve the cardiovascular health of cancerpatients.
Entities:
Keywords:
Cardio-oncology; Cardiotoxicity; Multidisciplinary units
Authors: Frank Daniel Martos-Benítez; Caridad de Dios Soler-Morejón; Karla Ximena Lara-Ponce; Versis Orama-Requejo; Dailé Burgos-Aragüez; Hilev Larrondo-Muguercia; Rahim W Lespoir Journal: World J Clin Oncol Date: 2020-10-24